Allée de la Recherche, 60
Brussels 1070
Belgium
32 2 559 99 99
https://www.ucb.com
Setor(es): Healthcare
Indústria: Biotechnology
Funcionários Integrais: 8.450
Nome | Título | Pagar | Exercido | Nascido em |
---|---|---|---|---|
Mr. Jean-Christophe Tellier | CEO & Executive Director | 4,1M | N/A | 1959 |
Ms. Sandrine Dufour CFA | Executive VP, CFO & Chief Corporate Development | N/A | N/A | 1966 |
Dr. Kirsten Lund-Jurgensen Ph.D. | Executive Vice President of Supply & Technology Solutions | N/A | N/A | 1960 |
Dr. Dhavalkumar D. Patel M.D., Ph.D. | Executive VP & Chief Scientific Officer | N/A | N/A | 1961 |
Ms. Denelle J. Waynick Johnson J.D. | Executive VP & General Counsel | N/A | N/A | 1967 |
Mr. Jean-Luc Fleurial | Executive VP & Chief Human Resources Officer | N/A | N/A | 1965 |
Prof. Iris Low-Friedrich | Executive VP & Chief Medical Officer | N/A | N/A | 1960 |
Mr. Emmanuel Caeymaex | Executive VP of Immunology Solutions & Head of US | N/A | N/A | 1969 |
Ms. Caroline Vancoillie | Chief Accounting Officer, Head of Group Finance & CFO of Patient Value Functions | N/A | N/A | N/A |
Antje Witte | Head of Investor Relations | N/A | N/A | N/A |
O QualityScore de governança da ISS da UCB SA a partir de 1 de maio de 2024 é 2. As principais pontuações para Auditoria são: 1; Conselho: 2; Direitos de Acionistas: 1; Compensação: 4.